• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存在肌肉减少症及其变化率与肝硬化患者的长期死亡率独立相关。

Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis.

机构信息

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

出版信息

J Korean Med Sci. 2018 Oct 31;33(50):e299. doi: 10.3346/jkms.2018.33.e299. eCollection 2018 Dec 10.

DOI:10.3346/jkms.2018.33.e299
PMID:30534029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6281953/
Abstract

BACKGROUND

Sarcopenia is associated with a poor prognosis in patients with liver cirrhosis. However, it is not known whether the rate of skeletal muscle depletion is also associated with a poor prognosis. We investigated the prognostic impact of the rate of skeletal muscle depletion in patients with liver cirrhosis.

METHODS

We included retrospectively all patients with liver cirrhosis who underwent both multiple computed tomography scans and hepatic venous pressure gradient (HVPG) measurements.

RESULTS

A total of 131 patients with liver cirrhosis were enrolled. The mean age of the patients was 53.7 years and alcoholic liver disease was the most common cause (61.8%). Sixty-four patients (48.9%) were diagnosed with sarcopenia. The median changes in skeletal muscle area per year (ΔSMA/y) were -0.89%. During a median follow-up period of 46.2 months (range, 3.4-87.6), 45 patients (34.4%) died. In multivariate analyses, age, Child-Pugh score, HVPG, presence of sarcopenia and ΔSMA/y were independently associated with mortality. Cumulative mortality was significantly higher in patients with ΔSMA/y < -2.4% than those with ΔSMA/y ≥ -2.4% (log-rank test, < 0.001).

CONCLUSION

Both the presence and rate of change of sarcopenia are independently associated with long-term mortality in patients with liver cirrhosis.

摘要

背景

肌肉减少症与肝硬化患者的预后不良相关。然而,骨骼肌耗竭的速度是否也与预后不良相关尚不清楚。我们研究了肝硬化患者骨骼肌耗竭速度对预后的影响。

方法

我们回顾性纳入了所有接受多次 CT 扫描和肝静脉压力梯度(HVPG)测量的肝硬化患者。

结果

共纳入 131 例肝硬化患者,患者的平均年龄为 53.7 岁,最常见的病因是酒精性肝病(61.8%)。64 例(48.9%)患者被诊断为肌肉减少症。骨骼肌面积每年的变化中位数(ΔSMA/y)为-0.89%。在中位随访时间为 46.2 个月(范围 3.4-87.6)期间,45 例患者(34.4%)死亡。多变量分析显示,年龄、Child-Pugh 评分、HVPG、肌肉减少症的存在和ΔSMA/y 与死亡率独立相关。ΔSMA/y < -2.4%的患者累积死亡率明显高于ΔSMA/y ≥ -2.4%的患者(对数秩检验, < 0.001)。

结论

肌肉减少症的存在和变化速度均与肝硬化患者的长期死亡率独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/d87b1bbd0eeb/jkms-33-e299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/27b09e039275/jkms-33-e299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/cd431ba5c494/jkms-33-e299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/d87b1bbd0eeb/jkms-33-e299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/27b09e039275/jkms-33-e299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/cd431ba5c494/jkms-33-e299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be13/6281953/d87b1bbd0eeb/jkms-33-e299-g003.jpg

相似文献

1
Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis.存在肌肉减少症及其变化率与肝硬化患者的长期死亡率独立相关。
J Korean Med Sci. 2018 Oct 31;33(50):e299. doi: 10.3346/jkms.2018.33.e299. eCollection 2018 Dec 10.
2
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis.酒精相关性肝病增加肝硬化患者肌肉减少症和死亡率的风险。
J Gastroenterol. 2024 Oct;59(10):932-940. doi: 10.1007/s00535-024-02137-4. Epub 2024 Jul 28.
3
Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis.快速的骨骼肌消耗预示着肝硬化患者的生存预后更差。
Hepatol Res. 2016 Jul;46(8):743-51. doi: 10.1111/hepr.12616. Epub 2016 Jan 28.
4
Adipopenia correlates with higher portal pressure in patients with cirrhosis.脂肪减少与肝硬化患者的门静脉高压相关。
Liver Int. 2019 Sep;39(9):1672-1681. doi: 10.1111/liv.14175. Epub 2019 Jul 2.
5
Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.肌肉减少症对肝硬化预后价值的影响:超越肝静脉压力梯度和 MELD 评分。
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):860-870. doi: 10.1002/jcsm.12333.
6
Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.严重的肌肉消耗预测术后住院时间,但与肝移植后的生存率无关。
Liver Transpl. 2014 Jun;20(6):640-8. doi: 10.1002/lt.23863. Epub 2014 Mar 26.
7
Sarcopenia impairs prognosis of patients with liver cirrhosis.肌肉减少症会损害肝硬化患者的预后。
Nutrition. 2015 Jan;31(1):193-9. doi: 10.1016/j.nut.2014.07.005. Epub 2014 Jul 30.
8
The relationship between imaging-based body composition abnormalities and long-term mortality in patients with liver cirrhosis.基于影像学的人体成分异常与肝硬化患者长期死亡率的关系。
Eur J Radiol. 2024 Nov;180:111707. doi: 10.1016/j.ejrad.2024.111707. Epub 2024 Aug 26.
9
Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.肝静脉压力梯度可预测失代偿期肝硬化患者的长期死亡率。
Yonsei Med J. 2016 Jan;57(1):138-45. doi: 10.3349/ymj.2016.57.1.138.
10
Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis.袢利尿剂对肝硬化患者骨骼肌消耗的影响。
Hepatol Res. 2019 Jan;49(1):82-95. doi: 10.1111/hepr.13244. Epub 2018 Sep 25.

引用本文的文献

1
Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis.肌肉量动态变化与肝硬化患者长期肝脏相关死亡率独立相关。
Heliyon. 2024 Aug 3;10(15):e35354. doi: 10.1016/j.heliyon.2024.e35354. eCollection 2024 Aug 15.
2
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis.酒精相关性肝病增加肝硬化患者肌肉减少症和死亡率的风险。
J Gastroenterol. 2024 Oct;59(10):932-940. doi: 10.1007/s00535-024-02137-4. Epub 2024 Jul 28.
3
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis.

本文引用的文献

1
Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.支链氨基酸(BCAAs)对晚期肝病进展的影响:一项韩国全国性、多中心、回顾性、观察性队列研究。
Medicine (Baltimore). 2017 Jun;96(24):e6580. doi: 10.1097/MD.0000000000006580.
2
Branched-chain amino acids for people with hepatic encephalopathy.用于肝性脑病患者的支链氨基酸
Cochrane Database Syst Rev. 2017 May 18;5(5):CD001939. doi: 10.1002/14651858.CD001939.pub4.
3
Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
根据欧洲肝脏研究学会/美国肝病研究学会基于计算机断层扫描的标准评估的肌肉减少症可预测肝硬化患者的死亡率:一项系统评价和荟萃分析。
JHEP Rep. 2024 May 6;6(8):101113. doi: 10.1016/j.jhepr.2024.101113. eCollection 2024 Aug.
4
Serum zinc concentration as a potential predictor of presarcopenia in patients with chronic liver disease: a preliminary study.血清锌浓度作为慢性肝病患者潜在的肌少症前期预测指标:一项初步研究。
Transl Gastroenterol Hepatol. 2024 Apr 1;9:20. doi: 10.21037/tgh-23-77. eCollection 2024.
5
Correlation between sarcopenia and cirrhosis: a meta-analysis.肌肉减少症与肝硬化之间的相关性:一项荟萃分析。
Front Nutr. 2024 Jan 10;10:1342100. doi: 10.3389/fnut.2023.1342100. eCollection 2023.
6
Assessing the risk factors associated with sarcopenia in patients with liver cirrhosis: a case-control study.评估肝硬化患者肌少症相关的危险因素:一项病例对照研究。
Sci Rep. 2023 Dec 9;13(1):21845. doi: 10.1038/s41598-023-48955-z.
7
Sarcopenia defined with L3-SMI is an independent predictor of survival in male patients with ARLD in mainland China.采用L3-骨骼肌指数定义的肌肉减少症是中国大陆地区成年男性酒精性肝病患者生存的独立预测因素。
Front Nutr. 2023 Sep 15;10:1238433. doi: 10.3389/fnut.2023.1238433. eCollection 2023.
8
Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis.简单的床边肌肉力量和功能测试与计算机断层扫描骨骼肌指数相关,可用于评估肝硬化患者的肌肉减少症。
Indian J Gastroenterol. 2023 Jun;42(3):379-387. doi: 10.1007/s12664-023-01338-8. Epub 2023 May 24.
9
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.全球酒精相关性肝病的患病率、发病率和结局:系统评价和荟萃分析。
BMC Public Health. 2023 May 11;23(1):859. doi: 10.1186/s12889-023-15749-x.
10
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.非酒精性脂肪性肝病/代谢相关脂肪性肝病中的肌少症骨量减少症:慢性肝病中一个被低估的临床问题。
Int J Mol Sci. 2023 Apr 19;24(8):7517. doi: 10.3390/ijms24087517.
计算机断层扫描衍生的骨骼肌指数:经导管主动脉瓣置换术后虚弱和住院时间的新型预测指标。
Am Heart J. 2016 Dec;182:21-27. doi: 10.1016/j.ahj.2016.08.016. Epub 2016 Sep 12.
4
Welcome to the ICD-10 code for sarcopenia.欢迎使用 ICD-10 代码来诊断肌少症。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-514. doi: 10.1002/jcsm.12147. Epub 2016 Oct 17.
5
ESPEN guidelines on definitions and terminology of clinical nutrition.ESPEN 临床营养定义和术语指南。
Clin Nutr. 2017 Feb;36(1):49-64. doi: 10.1016/j.clnu.2016.09.004. Epub 2016 Sep 14.
6
Sarcopenia from mechanism to diagnosis and treatment in liver disease.肝脏疾病中肌肉减少症:从机制到诊断与治疗
J Hepatol. 2016 Dec;65(6):1232-1244. doi: 10.1016/j.jhep.2016.07.040. Epub 2016 Aug 8.
7
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.睾酮治疗可增加低睾酮血症肝硬化男性的肌肉量:一项随机对照试验。
J Hepatol. 2016 Nov;65(5):906-913. doi: 10.1016/j.jhep.2016.06.007. Epub 2016 Jun 14.
8
Sarcopenia, Frailty, and Diabetes in Older Adults.老年人的肌肉减少症、衰弱症与糖尿病
Diabetes Metab J. 2016 Jun;40(3):182-9. doi: 10.4093/dmj.2016.40.3.182. Epub 2016 Apr 21.
9
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.肌肉减少症对实体瘤成年患者的预后价值:一项荟萃分析与系统评价
Eur J Cancer. 2016 Apr;57:58-67. doi: 10.1016/j.ejca.2015.12.030. Epub 2016 Feb 13.
10
Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.综述文章:肝硬化中的肌肉减少症——病因、影响及潜在治疗干预措施
Aliment Pharmacol Ther. 2016 Apr;43(7):765-77. doi: 10.1111/apt.13549. Epub 2016 Feb 5.